Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis.
Mycobacterium tuberculosis is estimated to infect 80 to 100 million people annually, the majority of whom do not develop clinical tuberculosis (TB) but instead maintain the infection in a latent state. These individuals generally become positive in response to a tuberculin skin test and may develop...
Main Authors: | Demissie, A, Leyten, E, Abebe, M, Wassie, L, Aseffa, A, Abate, G, Fletcher, H, Owiafe, P, Hill, P, Brookes, R, Rook, G, Zumla, A, Arend, S, Klein, M, Ottenhoff, T, Andersen, P, Doherty, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2.
by: Demissie, A, et al.
Published: (2004) -
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.
by: Fletcher, H, et al.
Published: (2004) -
Identifying mixed Mycobacterium tuberculosis infection and laboratory cross-contamination during mycobacterial sequencing programs
by: Wyllie, D, et al.
Published: (2018) -
Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
by: Marsay, L, et al.
Published: (2013) -
Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
by: Marsay, L, et al.
Published: (2013)